Search
for
Sort by
Research 121–150 of 1000+
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Effects of 5-alpha reductase inhibitors
- GC-MS Fatty Acid Profile and In silico Studies of Telfairia occidentalis Hook f. (Fluted Pumpkin) and Sphenostylis stenocarpa (African Yam bean) Seeds Oil on Human 5 Alpha Reductase II
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell Culture
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- Cutaneous drug reactions
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
- High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- DRUG‐ASSOCIATED ALOPECIA
- The role of lymphocytes in the development and treatment of alopecia areata
- Idiopathic Hirsutism*
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- INDUCTION OF PSORIASIFORM CHANGES IN GUINEA PIG SKIN BY PROPRANOLOL
- Organizadores e cortadores de comprimidos: riscos e restrições ao uso
- Ciclosporin-Induced Generalised Hypertrichosis in a Transgender Woman Receiving Testosterone Blockers
- Immune Microenvironment of Hair Follicles in Tumor Immunotherapy
- Intraoperative Iris Behavior during Phacoemulsification Maneuvers in Rabbits Treated with Selective α1-Blocker, 5α-Reductase Inhibitor, or Anxiolytic Medication
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- The relation between androgenetic thin hair diagnosed by trichoscope and benign prostatic hyperplasia